Rich metadata for richer results

Edelweiss Connect was at Bio-IT World in Boston in April to launch our new EdelweissData™ platform and the event also proved to be a great opportunity to listen to the community. The conference program promised to “separate the hype from the reality” about what burgeoning new technologies like Blockchain, AI, machine learning, etc., are actually delivering to the toxicology and pharmacy fields. One of the messages that Daniel Bachler, Principal Software Architect, took away is the “interesting disconnect between what tech providers want to talk about - i.e., ‘We are doing so much AI with so much success!’ - and what seems to be the reality on the ground”.

Daniel was particularly struck by how AI is changing the value of metadata. “Several speakers in the keynote address expressed issues around metadata handling. It seems that, very often, scientists do ok with capturing the main data of experiments, etc., but a lot of metadata is often not properly captured – and, then, it turns out that the metadata would have been important to enable interesting AI approaches. One example that came up was a paper about how keeping mice in warmer conditions than usual (30°C instead of 20°) radically changed some experimental outcomes - yet, it is almost impossible to find out at what temperature mice were kept in historical experiments as these things were only vaguely described in text, often referencing even older experiments that didn't record these settings, either.”

Daniel is part of the Edelweiss Connect team developing the EdelweissData platform to store rich metadata. He notes that our work with EU-ToxRisk, ACEnano, and NanoCommons is already informed by the need to capture information rigorously that could have later importance to research.

About Edelweiss Connect

Edelweiss Connect has developed computer software that helps combine data from many different sources and formats into a useable form for evaluation and re-use. In addition, we have developed other software programs that can use the collected data and data from in vitro tests to predict the safety of chemical compounds in the human body.

Tags

Latest Tweets

Edelweiss Connect (2 weeks ago)
RT @EU_ToxRisk: The EU-ToxRisk NAM-based Testing Commercialization Platform presented during the @EU_ToxRisk Open Symposium, Feb 12, 2020 i…
Edelweiss Connect (2 weeks ago)
RT @Biopredic_Intl: We are glad to announce the launch of the new HepaRG #logo !! Worldwide recognized and quite unique human hepatic stem…
Edelweiss Connect (3 weeks ago)
The SafeDESIgn imaging-based toxicity reporter platform for chemical safety assessment #SaferWorldbyDesign… https://t.co/7xeN1d6w6t
Edelweiss Connect (5 weeks ago)
The latest #OpenTox webinar focused on #AOPs current trends and developments, presented by Tatyana Doktorova https://t.co/ZKj5PivfiN
Edelweiss Connect (5 weeks ago)
RT @barryhardy: Tatyana Doktorova will discuss current trends and developments in Adverse Outcome Pathways as exemplified by case studies (…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA